Guangji Zhang Selected Research

Philadelphia Chromosome

1/2021	A Higher Dose of Dasatinib May Increase the Possibility of Crossing the Blood-brain Barrier in the Treatment of Patients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
10/2020	Adjuvant ruxolitinib therapy relieves steroid-refractory cytokine-release syndrome without impairing chimeric antigen receptor-modified T-cell function.
3/2019	Nilotinib combined with multi-agent chemotherapy in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center prospective study with long-term follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guangji Zhang Research Topics

Disease

16	Neoplasms (Cancer) 04/2024 - 11/2015
6	Stomach Neoplasms (Stomach Cancer) 01/2024 - 11/2015
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 02/2016
5	Leukemia 09/2021 - 01/2015
4	Lung Neoplasms (Lung Cancer) 05/2024 - 01/2016
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 03/2019
3	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2019
3	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2016
3	Philadelphia Chromosome 01/2021 - 03/2019
2	Acute Promyelocytic Leukemia 12/2022 - 04/2022
1	Glioblastoma (Glioblastoma Multiforme) 12/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2023
1	Necrosis 11/2023
1	Metaplasia 06/2023
1	Atrophic Gastritis 06/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Hyperplasia 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Weight Loss (Weight Reduction) 10/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Cytokine Release Syndrome 10/2020
1	Candidemia 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Carcinogenesis 01/2020
1	Hypoxia (Hypoxemia) 10/2019
1	Pathologic Processes 01/2019
1	Neutropenia 01/2017
1	Infections 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2016
5	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2022 - 12/2014
3	DiterpenesIBA 05/2024 - 01/2016
3	Arsenic Trioxide (Trisenox)FDA Link 12/2022 - 11/2015
3	venetoclaxIBA 04/2022 - 09/2021
2	Therapeutic UsesIBA 12/2023 - 01/2022
2	Chimeric Antigen ReceptorsIBA 11/2023 - 10/2020
2	LipidsIBA 01/2021 - 01/2020
2	cryptotanshinoneIBA 02/2017 - 02/2017
1	Plant ExtractsIBA 04/2024
1	EnzymesIBA 02/2024
1	ImmunosorbentsIBA 02/2024
1	Hematoxylin (Haematoxylon)IBA 02/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2024
1	beta-elemeneIBA 02/2024
1	PhytochemicalsIBA 02/2024
1	elemeneIBA 02/2024
1	GTP-Binding Proteins (G-Protein)IBA 01/2024
1	Ganciclovir (Cytovene)FDA LinkGeneric 12/2023
1	Fluorouracil (Carac)FDA LinkGeneric 11/2023
1	TabletsIBA 06/2023
1	Nonprescription Drugs (Patent Medicines)IBA 06/2023
1	Caspase 3 (Caspase-3)IBA 06/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2022
1	HomoharringtonineIBA 04/2022
1	Benzo(a)pyreneIBA 01/2022
1	CarcinogensIBA 01/2022
1	Huangqin-TangIBA 01/2022
1	Claudin-1IBA 01/2022
1	OccludinIBA 01/2022
1	Sucrose (Saccharose)IBA 10/2021
1	alanyl-leucyl-alanyl-leucine (ALAL)IBA 09/2021
1	Azacitidine (5 Azacytidine)FDA Link 09/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	sodium-bile acid cotransporterIBA 01/2021
1	Cytochrome P450 Family 7IBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	ruxolitinibIBA 10/2020
1	SteroidsIBA 10/2020
1	CytokinesIBA 10/2020
1	Janus KinasesIBA 10/2020
1	Amino Acids FDA Link 01/2020
1	Antifungal AgentsIBA 01/2020
1	Sterol Regulatory Element Binding ProteinsIBA 01/2020
1	Photosensitizing Agents (Photosensitizers)IBA 10/2019
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2019
1	AlbuminsIBA 10/2019
1	nilotinib FDA Link 03/2019
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Core Binding Factors (Core-Binding Factor)IBA 10/2018
1	CBFbeta-MYH11 fusion proteinIBA 10/2018
1	Apoptosis Regulatory ProteinsIBA 02/2017
1	Interleukin-6 (Interleukin 6)IBA 02/2017
1	SurvivinIBA 02/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2017
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2017
1	evodiamineIBA 01/2017
1	HLA-DR Antigens (HLA-DR)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2017

Therapy/Procedure

10	Therapeutics 02/2024 - 01/2015
6	Drug Therapy (Chemotherapy) 09/2021 - 01/2015
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2016
2	Immunotherapy 04/2024 - 01/2022
1	Immunomodulation 04/2024
1	Photochemotherapy (Photodynamic Therapy) 10/2019
1	Induction Chemotherapy 01/2017
1	Consolidation Chemotherapy 01/2017